We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Inhibiting NLRP3 To Prevent Melanoma-Mediated Inflammation

News   Apr 08, 2021 | Original story from University of Colorado Anschutz Medical Campus

 
Inhibiting NLRP3 To Prevent Melanoma-Mediated Inflammation

Human metastatic melanoma cells stained with an H & E stain and magnified to 320x. Credit: Dr Lance Liotta Laboratory

 
 
Advertisement
 

RELATED ARTICLES

IL-33 Implicated in SARS-CoV-2 Immunity

News

Researchers have unveiled a novel feature of COVID-19 immunity, which could have implications for future therapies. The study points to the involvement of Interleukin 33 when immune cells encounter Sars-CoV-2 for a second time.

READ MORE

Conserved Antibody Binding-Site Identified Across COVID-19 Variants

News

Scientists have uncovered the first full structure of the coronavirus nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with it. They also determined that the structure appears similar across many coronaviruses, including recent COVID-19 variants — making it an ideal target for advanced treatments and vaccines.

READ MORE

Researchers Develop a Better Method To Culture Cells for Testing Drug Toxicity

News

Researchers have found a way to make liver cancer cells behave more like normal liver cells, allowing drugs to be screened for toxicity earlier in the research timeline.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE